SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ECN'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 11 / 12 | ILE B 25PHE B 28TYR B 29ALA B 56LEU B 57VAL B 61HIS B 85TRP B 122ALA B 125TYR B 126LEU B 129 | ECN B 411 (-4.5A)ECN B 411 (-4.0A)NoneECN B 411 (-3.5A)ECN B 411 (-4.1A)DGG B 406 ( 4.8A)HEM B 404 (-3.3A)NoneDGG B 406 ( 3.8A)HEM B 404 ( 3.9A)HEM B 404 ( 4.3A) | 0.31A | 3ozuA-3ozvB:46.1 | 3ozuA-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 11 / 12 | PHE B 28TYR B 29ALA B 56LEU B 57VAL B 61HIS B 85LEU B 102TRP B 122ALA B 125TYR B 126LEU B 129 | ECN B 411 (-4.0A)NoneECN B 411 (-3.5A)ECN B 411 (-4.1A)DGG B 406 ( 4.8A)HEM B 404 (-3.3A)ECN B 411 (-3.2A)NoneDGG B 406 ( 3.8A)HEM B 404 ( 3.9A)HEM B 404 ( 4.3A) | 0.24A | 3ozuA-3ozvB:46.1 | 3ozuA-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) |
4g1b | FLAVOHEMOGLOBIN (Saccharomycescerevisiae) | 5 / 12 | ALA A 56LEU A 57VAL A 61TRP A 122ALA A 125 | ECN A 403 (-3.8A)ECN A 403 (-2.7A)ECN A 403 ( 4.7A)NoneNone | 0.65A | 3ozuA-4g1bA:34.9 | 3ozuA-4g1bA:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) |
4g1b | FLAVOHEMOGLOBIN (Saccharomycescerevisiae) | 5 / 12 | PHE A 28TYR A 29LEU A 102ALA A 125TYR A 126 | ECN A 403 (-3.6A)ECN A 403 (-4.8A)ECN A 403 (-3.8A)NoneECN A 403 (-4.7A) | 0.52A | 3ozuA-4g1bA:34.9 | 3ozuA-4g1bA:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) |
4g1b | FLAVOHEMOGLOBIN (Saccharomycescerevisiae) | 5 / 12 | PHE A 28TYR A 29TRP A 122ALA A 125TYR A 126 | ECN A 403 (-3.6A)ECN A 403 (-4.8A)NoneNoneECN A 403 (-4.7A) | 0.39A | 3ozuA-4g1bA:34.9 | 3ozuA-4g1bA:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZV_B_ECNB411_1 (FLAVOHEMOGLOBIN) |
4g1b | FLAVOHEMOGLOBIN (Saccharomycescerevisiae) | 5 / 9 | ILE A 24PHE A 28TYR A 29LEU A 102ALA A 105 | ECN A 403 (-4.5A)ECN A 403 (-3.6A)ECN A 403 (-4.8A)ECN A 403 (-3.8A)ECN A 403 ( 4.5A) | 0.40A | 3ozvB-4g1bA:46.5 | 3ozvB-4g1bA:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZW_A_KKKA413_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 4 / 8 | ALA B 56LEU B 57LEU B 102PRO B 398 | ECN B 411 (-3.5A)ECN B 411 (-4.1A)ECN B 411 (-3.2A)HEM B 404 (-4.4A) | 0.73A | 3ozwA-3ozvB:62.3 | 3ozwA-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZW_A_KKKA413_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 6 / 8 | ILE B 25TYR B 29GLN B 50GLN B 53LEU B 57LEU B 102 | ECN B 411 (-4.5A)NoneFAD B 405 (-3.1A)HEM B 404 (-3.9A)ECN B 411 (-4.1A)ECN B 411 (-3.2A) | 0.65A | 3ozwA-3ozvB:62.3 | 3ozwA-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZW_A_KKKA413_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 6 / 8 | ILE B 25TYR B 29GLN B 53ALA B 56LEU B 57LEU B 102 | ECN B 411 (-4.5A)NoneHEM B 404 (-3.9A)ECN B 411 (-3.5A)ECN B 411 (-4.1A)ECN B 411 (-3.2A) | 0.49A | 3ozwA-3ozvB:62.3 | 3ozwA-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZW_B_KKKB413_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 10 / 12 | ILE B 25TYR B 29HIS B 47GLN B 52GLN B 53ALA B 56LEU B 57HIS B 85LEU B 102ILE B 371 | ECN B 411 (-4.5A)NoneNoneNoneHEM B 404 (-3.9A)ECN B 411 (-3.5A)ECN B 411 (-4.1A)HEM B 404 (-3.3A)ECN B 411 (-3.2A)None | 0.74A | 3ozwB-3ozvB:63.6 | 3ozwB-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OZW_B_KKKB413_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 11 / 12 | ILE B 25TYR B 29HIS B 47GLN B 53ALA B 56LEU B 57HIS B 85LEU B 102ILE B 371GLY B 397PRO B 398 | ECN B 411 (-4.5A)NoneNoneHEM B 404 (-3.9A)ECN B 411 (-3.5A)ECN B 411 (-4.1A)HEM B 404 (-3.3A)ECN B 411 (-3.2A)NoneFAD B 405 ( 4.4A)HEM B 404 (-4.4A) | 0.64A | 3ozwB-3ozvB:63.6 | 3ozwB-3ozvB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_A_ECNA403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 5 / 12 | PHE B 28PHE B 43GLN B 53VAL B 98TYR B 126 | ECN B 411 (-4.0A)HEM B 404 ( 3.8A)HEM B 404 (-3.9A)HEM B 404 ( 4.5A)HEM B 404 ( 3.9A) | 0.91A | 4g1bA-3ozvB:46.5 | 4g1bA-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_A_ECNA403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 6 / 12 | PHE B 28TYR B 29PHE B 43VAL B 98LEU B 102TYR B 126 | ECN B 411 (-4.0A)NoneHEM B 404 ( 3.8A)HEM B 404 ( 4.5A)ECN B 411 (-3.2A)HEM B 404 ( 3.9A) | 0.55A | 4g1bA-3ozvB:46.5 | 4g1bA-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_B_ECNB403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 6 / 11 | ILE B 24PHE B 28TYR B 29LEU B 57LEU B 102TYR B 126 | ECN B 411 (-3.5A)ECN B 411 (-4.0A)NoneECN B 411 (-4.1A)ECN B 411 (-3.2A)HEM B 404 ( 3.9A) | 0.83A | 4g1bB-3ozvB:46.3 | 4g1bB-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_B_ECNB403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 5 / 11 | ILE B 24PHE B 28TYR B 29LEU B 57VAL B 61 | ECN B 411 (-3.5A)ECN B 411 (-4.0A)NoneECN B 411 (-4.1A)DGG B 406 ( 4.8A) | 0.93A | 4g1bB-3ozvB:46.3 | 4g1bB-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_C_ECNC403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 5 / 9 | ILE B 24PHE B 28TYR B 29GLN B 53VAL B 61 | ECN B 411 (-3.5A)ECN B 411 (-4.0A)NoneHEM B 404 (-3.9A)DGG B 406 ( 4.8A) | 1.00A | 4g1bC-3ozvB:45.3 | 4g1bC-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_C_ECNC403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 6 / 9 | ILE B 24PHE B 28TYR B 29GLN B 53VAL B 98LEU B 102 | ECN B 411 (-3.5A)ECN B 411 (-4.0A)NoneHEM B 404 (-3.9A)HEM B 404 ( 4.5A)ECN B 411 (-3.2A) | 0.77A | 4g1bC-3ozvB:45.3 | 4g1bC-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_C_ECNC403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 5 / 9 | ILE B 24TYR B 29GLN B 53LEU B 57VAL B 61 | ECN B 411 (-3.5A)NoneHEM B 404 (-3.9A)ECN B 411 (-4.1A)DGG B 406 ( 4.8A) | 1.21A | 4g1bC-3ozvB:45.3 | 4g1bC-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_D_ECND403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 7 / 12 | ILE B 24PHE B 28TYR B 29PHE B 43LEU B 57LEU B 102TYR B 126 | ECN B 411 (-3.5A)ECN B 411 (-4.0A)NoneHEM B 404 ( 3.8A)ECN B 411 (-4.1A)ECN B 411 (-3.2A)HEM B 404 ( 3.9A) | 0.90A | 4g1bD-3ozvB:46.8 | 4g1bD-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_D_ECND403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 6 / 12 | ILE B 24PHE B 28TYR B 29PHE B 43LEU B 57VAL B 61 | ECN B 411 (-3.5A)ECN B 411 (-4.0A)NoneHEM B 404 ( 3.8A)ECN B 411 (-4.1A)DGG B 406 ( 4.8A) | 0.90A | 4g1bD-3ozvB:46.8 | 4g1bD-3ozvB:37.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G1B_D_ECND403_1 (FLAVOHEMOGLOBIN) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 5 / 12 | PHE B 28PHE B 43GLN B 53LEU B 102TYR B 126 | ECN B 411 (-4.0A)HEM B 404 ( 3.8A)HEM B 404 (-3.9A)ECN B 411 (-3.2A)HEM B 404 ( 3.9A) | 1.14A | 4g1bD-3ozvB:46.8 | 4g1bD-3ozvB:37.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_D_CVID301_1 (REGULATORY PROTEINTETR) |
3ozv | FLAVOHEMOGLOBIN (Cupriavidusnecator) | 4 / 8 | GLN B 52GLY B 51ILE B 25GLN B 30 | NoneNoneECN B 411 (-4.5A)None | 1.00A | 5vlmD-3ozvB:2.1 | 5vlmD-3ozvB:20.99 |